HeartSciences Inc. Stock: price and insider trades · United States
HeartSciences Inc.: what insiders have been doing
This page follows insider dealings at HeartSciences Inc. as filed with SEC (Form 4), a company from the Health Care sector. From 23 October 2025 to 23 October 2026, the disclosure feed for HeartSciences Inc. logged 2 filings by 1 insider.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Compared with its exchange (3,167 companies, median 24 filings), a count of 2 filings is below the norm. Our records for HeartSciences Inc. go back to 2024, with no purchases and 1 sale on the open market in total. For the fiscal year to 30 April 2026, the annual 10-K puts revenue at 4,319 USD and net income at -9.1 m USD.
Over the last twelve months, not one insider purchase of HeartSciences Inc. stock was filed.
Elsewhere in the same sector, our signals recently picked up insider purchases at Dynavox Group AB and EssilorLuxottica. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Who traded when
BuySaleThis score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2026FY ended April 2026 · cache
- 425,000 sharesCommon Stock, $0.001 par valueSEC:0001213900-26-071631:0
- 70,000 sharesCommon Stock, $0.001 par valueSEC:0001213900-25-116228:0
- 4,416 shares@ US$3.5374100.0% of flowCommon Stock, $0.001 par valueSEC:0001213900-25-069530:0
- 17 sharesCommon Stock, $0.001 par valueSEC:0001213900-24-069207:0
4 of 4 declarations
About HeartSciences Inc.
HeartSciences Inc. is a company focused on developing diagnostic solutions for heart diseases. It aims to leverage advanced technologies to enhance early detection of cardiac issues.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
